<i>Clostridium difficile</i> Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Total tests</td><td align="center">8543</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">All tests in patients with no CF</td><td align="center">8302</td></tr><tr><td align="left">Positive tests in patients with no CF</td><td align="center">1659 (20%)*</td></tr><tr><td align="left">All tests in CF patients</td><td align="center">241</td></tr><tr><td align="left">Positive tests in patients with CF</td><td align="center">86 (35.7%)*</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><i>
                *P</i> &lt; 0.05.<br/></td></tr></table>

Positive <i>C.  diff</i> tests for inpatient pediatric patients.

Gastroenterology Research and Practice

tab1

Table 1

Table 1: <i>Clostridium difficile</i> Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients 

Gastroenterology Research and Practice

Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients

Table 1